anmelden
Stoxx Europe 50
5.074,85
PKT
+4,13
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.04.24 | HSBC Neutral | UBS AG | |
| 09.04.24 | BP Buy | UBS AG | |
| 09.04.24 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Jefferies & Company Inc. | |
| 09.04.24 | AB InBev SA-NV (Anheuser-Busch InBev) Neutral | UBS AG | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 09.04.24 | Rheinmetall Buy | Goldman Sachs Group Inc. | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.04.24 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 09.04.24 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 08.04.24 | SAP Overweight | Barclays Capital | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | AB InBev SA-NV (Anheuser-Busch InBev) Outperform | RBC Capital Markets | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 08.04.24 | Siemens Outperform | RBC Capital Markets | |
| 08.04.24 | LOréal Overweight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | LOréal Underperform | Jefferies & Company Inc. | |
| 08.04.24 | Iberdrola SA Outperform | RBC Capital Markets | |
| 08.04.24 | Münchener Rückversicherungs-Gesellschaft Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | AB InBev SA-NV (Anheuser-Busch InBev) Hold | Deutsche Bank AG | |
| 08.04.24 | SAP Buy | UBS AG | |
| 08.04.24 | Allianz Neutral | UBS AG | |
| 05.04.24 | Allianz Buy | Jefferies & Company Inc. | |
| 05.04.24 | Prosus Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Enel Buy | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.04.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | VINCI Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. |